Literature DB >> 3089285

Localization of lysine residues in the binding domain of the K99 fibrillar subunit of enterotoxigenic Escherichia coli.

A A Jacobs, P A van den Berg, H J Bak, F K de Graaf.   

Abstract

Modification of lysine residues with 4-chloro-3,5-dinitrobenzoate results in the loss of the binding capacity of K99 fibrillae to horse erythrocytes (Jacobs, A.A.C., van Mechelen, J.R. and de Graaf, F.K. (1985) Biochim. Biophys. Acta 832, 148-155). In the present study we used dinitrobenzoate as a spectral probe to map the modified residues. After the incorporation of 0.7 mol CDNB per mol subunit, 90% of the binding activity disappeared and the lysine residues at positions 87, 132 and 133 incorporated 20%, 27.5% and 52.2% of the totally incorporated label, respectively. In the presence of the glycolipid receptor, Lys-132 and Lys-133 were partially protected against modification, while Lys-87 was not protected. The results suggest that Lys-132 and Lys-133 are part of the receptor-binding domain of the K99 fibrillar subunit and that the positive charges on these residues are important for the interaction of the fibrillae with the negatively charged sialic acid residue of the glycolipid receptor. A striking homology was found between a six-amino-acid residue segment of K99, containing Lys-132 and Lys-133, and segments of three other sialic-acid-specific lectins; cholera toxin B subunit, heat-labile toxin B subunit of Escherichia coli and CFA1 fimbrial subunit, suggesting that these segments might also be part of the receptor-binding domain in these three proteins.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3089285     DOI: 10.1016/0167-4838(86)90151-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

Review 1.  Animal Enterotoxigenic Escherichia coli.

Authors:  J Daniel Dubreuil; Richard E Isaacson; Dieter M Schifferli
Journal:  EcoSal Plus       Date:  2016-10

2.  Ganglioside epitope recognized by K99 fimbriae from enterotoxigenic Escherichia coli.

Authors:  E Ono; K Abe; M Nakazawa; M Naiki
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

3.  Glycoprotein glycans that inhibit adhesion of Escherichia coli mediated by K99 fimbriae: treatment of experimental colibacillosis.

Authors:  M Mouricout; J M Petit; J R Carias; R Julien
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

4.  Cloning, sequencing, and viscometric adhesion analysis of heat-resistant agglutinin 1, an integral membrane hemagglutinin from Escherichia coli O9:H10:K99.

Authors:  P Lutwyche; R Rupps; J Cavanagh; R A Warren; D E Brooks
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

5.  Group A streptococci bind to mucin and human pharyngeal cells through sialic acid-containing receptors.

Authors:  P A Ryan; V Pancholi; V A Fischetti
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

6.  Pilus-mediated binding of bovine enterotoxigenic Escherichia coli to calf small intestinal mucins.

Authors:  M A Mouricout; R A Julien
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

7.  Aqueous two-phase polymer systems as tools for the study of a recombinant surface-expressed Escherichia coli hemagglutinin.

Authors:  P Lutwyche; R Norris-Jones; D E Brooks
Journal:  Appl Environ Microbiol       Date:  1995-09       Impact factor: 4.792

8.  Cloning, nucleotide sequence, and expression of a gene encoding an adhesin subunit protein of Helicobacter pylori.

Authors:  D G Evans; T K Karjalainen; D J Evans; D Y Graham; C H Lee
Journal:  J Bacteriol       Date:  1993-02       Impact factor: 3.490

9.  The role of lysine-132 and arginine-136 in the receptor-binding domain of the K99 fibrillar subunit.

Authors:  A A Jacobs; B H Simons; F K de Graaf
Journal:  EMBO J       Date:  1987-06       Impact factor: 11.598

10.  Structural dynamics of SARS-CoV-2 variants: A health monitoring strategy for anticipating Covid-19 outbreaks.

Authors:  Jacques Fantini; Nouara Yahi; Fodil Azzaz; Henri Chahinian
Journal:  J Infect       Date:  2021-06-03       Impact factor: 6.072

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.